Cargando…

Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules

Background: The response time-course information of biologics and small targeted molecules for the treatment of moderate to severe plaque psoriasis which helps clinicians to understand the onset of action and maintenance of effect are unclear. Quantitative information about the efficacy comparation...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Huan, Wu, Wenwen, Zhang, Yi, Zhang, Meng, Sun, Ning, Zhao, Libo, Wang, Xiaoling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281289/ https://www.ncbi.nlm.nih.gov/pubmed/34276352 http://dx.doi.org/10.3389/fphar.2021.586827

Ejemplares similares

Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn’s Disease
por: Yu, Boran, et al.
Publicado: (2022)

Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis
por: Zhou, Erye, et al.
Publicado: (2023)

Small molecules targeting Pin1 as potent anticancer drugs
por: Zhang, Jing, et al.
Publicado: (2023)

The Role of Co-Signaling Molecules in Psoriasis and Their Implications for Targeted Treatment
por: Liu, Suqing, et al.
Publicado: (2021)

Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer
por: Zhang, Xue, et al.
Publicado: (2022)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
por: Su, Chao-Yue, et al.
Publicado: (2023)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis
por: Vugler, Alexander, et al.
Publicado: (2022)

Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
por: Cai, Jiangluyi, et al.
Publicado: (2021)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023)

TAIGET: A small-molecule target identification and annotation web server
por: Wei, Xuxu, et al.
Publicado: (2022)

Effective holistic characterization of small molecule effects using heterogeneous biological networks
por: Mangione, William, et al.
Publicado: (2023)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022)

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
por: Li, Ping, et al.
Publicado: (2017)

Xiyanping injection combined with acitretin for psoriasis vulgaris: A systematic review and meta-analysis
por: Wu, Man-Ning, et al.
Publicado: (2022)

Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond
por: Davidson, David, et al.
Publicado: (2013)

Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
por: Uddin, Md. Sahab, et al.
Publicado: (2021)

Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction
por: Rahman, Md. Ataur, et al.
Publicado: (2022)

Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
por: Caputo, Valerio, et al.
Publicado: (2021)

Persistence and Adherence to Biologics in Patients with Psoriasis in Taiwan: A New Biologics User Cohort Study
por: Huang, Yu-Huei, et al.
Publicado: (2022)

Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist S6 Stimulates Insulin Secretion From Rat Islets
por: Yang, Xiaohua, et al.
Publicado: (2021)

Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression
por: Yu, Ming, et al.
Publicado: (2022)

Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future
por: Yao, Jiaqi, et al.
Publicado: (2023)

Editorial: Targeting autophagy in Cancer Therapy: Focus on small-molecule modulators and new strategies
por: Pluta, Ryszard
Publicado: (2023)

Rational Design of A Novel Small-Molecule HIV-1 Inactivator Targeting Both gp120 and gp41 of HIV-1
por: Pu, Jing, et al.
Publicado: (2021)

Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole
por: Udawatte, Nadeeka S., et al.
Publicado: (2020)

Biologicals and small molecules in psoriasis: A systematic review of economic evaluations
por: Kromer, Christian, et al.
Publicado: (2018)

Integrated Pharmacological Analysis on the Mechanism of Fuyou Formula in Treating Precocious Puberty
por: Guo, Chunyan, et al.
Publicado: (2021)

Small Molecule Inhibitors of CRM1
por: Ferreira, Bibiana I., et al.
Publicado: (2020)

Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy
por: Belizário, José E., et al.
Publicado: (2016)

Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
por: Bulatov, Emil, et al.
Publicado: (2018)

Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma
por: Zhou, Yongxu, et al.
Publicado: (2023)

Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
por: Zhang, Lijuan, et al.
Publicado: (2022)

Selumetinib - a potential small molecule inhibitor for osteoarthritis treatment
por: Zheng, Xiaohang, et al.
Publicado: (2022)

Antioxidant Small Molecule Compound Chrysin Promotes the Self-Renewal of Hematopoietic Stem Cells
por: Li, Yinghui, et al.
Publicado: (2020)

In Vivo Dopamine Neuron Imaging-Based Small Molecule Screen Identifies Novel Neuroprotective Compounds and Targets
por: Kim, Gha-hyun J., et al.
Publicado: (2022)

Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules
por: Bellinato, Francesco, et al.
Publicado: (2021)

Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor
por: Qi, Xin, et al.
Publicado: (2022)

Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials
por: Di Lernia, Vito, et al.
Publicado: (2022)

Synthetic Biology Speeds Up Drug Target Discovery
por: Xie, Yixuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mkp76t2bcsdtuvbjek8dhkpejm